Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 2276: Sorafenib/Refametinib potently inhibits Wnt/β-catenin in vitro and patient-derived xenograft models of human hepatocellular carcinoma

Cancer Res (2016) 76 (14_Supplement): 2276.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Seyed Alireza Javadinia
  • Soodabeh Shahidsales
  • Azar Fanipakdel
  • Mona Joudi‐Mashhad
  • Mehrane Mehramiz
  • Sahar Talebian
  • Mona Maftouh
  • Ramin Mardani
  • Seyed Mahdi Hassanian
  • Majid Khazaei
  • Gordon A. Ferns
  • Amir Avan
Journal of Cellular Biochemistry (2019) 120 (5): 6833.
  • Nithya Krishnamurthy
  • Razelle Kurzrock
Cancer Treatment Reviews (2018) 62: 50.
Close Modal

or Create an Account

Close Modal
Close Modal